| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.94% | 52.94% | -60.95% | 10/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 12.65% | 172.04% | 44.24% | 11/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 8.77% | 188.49% | 47.64% | 18/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 5.94% | 375.2% | 83.9% | 18/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 3.23% | 171.43% | -30.54% | 19/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 4.65% | -36.56% | 52.96% | 36/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 3.04% | -58.92% | 143.2% | 42/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 1.25% | -73.18% | 5.04% | 47/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 1.19% | -64.48% | -83.77% | 45/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 7.33% | -46.69% | -0.95% | 33/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.4% | -28.91% | 58.8% | 31/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 4.66% | -35.37% | 39.1% | 35/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.35% | 4.04% | -75.64% | 29/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 13.75% | -31.04% | 32.08% | 13/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 10.41% | -37.18% | 44.38% | 18/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 7.21% | -42.27% | 123.91% | 14/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 3.22% | -47.21% | -83.85% | 18/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 19.94% | -12.7% | 20.34% | 3/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 16.57% | -14.89% | 32.67% | 4/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 12.49% | -1.65% | 104.75% | 2/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 6.1% | -4.09% | -73.29% | 4/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 22.84% | 59.83% | 17.31% | 1/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 19.47% | 130.96% | 53.31% | 1/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 12.7% | 156.05% | 99.69% | 1/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 6.36% | 182.67% | -55.49% | 3/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 14.29% | 95.49% | 69.51% | 10/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 8.43% | 4.46% | 69.96% | 27/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 4.96% | -24.51% | 120.44% | 33/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 2.25% | -27.18% | -69.22% | 39/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 7.31% | -31.55% | -9.42% | 42/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 8.07% | -31.49% | 22.83% | 29/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 6.57% | -4.09% | 112.62% | 24/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 3.09% | -18.25% | -71.07% | 27/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 10.68% | 11.6% | -9.34% | 30/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 11.78% | 32.96% | 71.97% | 11/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 6.85% | 38.38% | 81.22% | 23/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 3.78% | 17.03% | -60.5% | 18/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 9.57% | 4.25% | 8.01% | 35/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 8.86% | 0.91% | 78.99% | 26/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 4.95% | 12.76% | 53.25% | 36/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 3.23% | 12.94% | -64.81% | 25/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |

微信公众号
证券之星APP


